Candel therapeutics announces three abstracts accepted for poster presentations at sitc 2023 annual meeting

Needham, mass., sept. 27, 2023 (globe newswire) -- candel therapeutics, inc. (nasdaq: cadl), a clinical stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer, today announced the company will present three posters at the society for immunotherapy of cancer's (sitc) 38th annual meeting taking place november 3-5, 2023 in san diego, ca and virtually.
CADL Ratings Summary
CADL Quant Ranking